Literature DB >> 11895441

Construction and characterization of trifunctional single-chain urokinase-type plasminogen activators.

Qun Bi1, Xiaodong Cen, Yixiu Huang, Shenggeng Zhu.   

Abstract

Two chimeric proteins have been constructed. One consists of four parts: a portion of the low molecular mass single-chain urokinase-type plasminogen activator (scu-PA-32K, residues 144-411), a 15-mer linker sequence, the C-terminal amino-acid sequence (residues 53-65) of hirudin (Hir), and an RGD sequence derived from the leech protein decorsin, i.e. scu-PA(32 k)-linker-Hir (residues 53-65)-RGD peptide. The other comprises two main segments: scu-PA(32 k) and hirudin into which RGDSP is inserted between its residues 33 and 34, i.e. hirudin (residues 1-33)-RGDSP-hirudin (residues 34-65)-scu-PA(32 k). These two chimeric genes were expressed in Escherichia coli, and the products were purified by Zn2+-chelating Sepharose 4B chromatography and benzamidine Sepharose 6B chromatography. Our results suggested that these two chimeric proteins not only had plasminogen-dependent fibrinolytic activity, but also possessed platelet aggregation inhibitory activity and antithrombin activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895441     DOI: 10.1046/j.1432-1327.2002.02816.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides.

Authors:  Wu Chen; Yi Li; Pin Chen; Maocai Wu; Lihua Wang; Hua Zhang; Laiyou Wang
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

2.  In vitro characterization of a multifunctional staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158.

Authors:  K K Pulicherla; Anmol Kumar; G S Gadupudi; Seetha Ram Kotra; K R S Sambasiva Rao
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

3.  Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities.

Authors:  Hongshan Chen; Wei Mo; Huabo Su; Yanling Zhang; Houyan Song
Journal:  BMC Mol Biol       Date:  2007-10-07       Impact factor: 2.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.